Immunovant Inc reports results for the quarter ended in March - Earnings Summary

Immunovant

08/06/2022 12:35

* Immunovant Inc  IMVT.OQ  reported a quarterly adjusted
loss
of 29 cents​​ per share for the quarter ended in March. The mean
expectation of nine analysts for the quarter was for a loss
of 38 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Immunovant Inc's reported EPS for the quarter was a loss
of 29
cents​.
    * The mean earnings estimate of analysts had fallen by
about 2.9%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Immunovant Inc shares had fallen by 22.5% this quarter and
lost 49.9% so far this year.
    * The company reported a quarterly loss of $47.17 million.
    * Wall Street's median 12-month price target for Immunovant
Inc is
$12.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated June 8 at 11:34 a.m.  ​All
figures in US dollars unless otherwise stated